Abstract
Neuromuscular blockade is used in the operating room and in the intensive care unit. While in the operating room, almost every patient undergoing general anesthesia receives neuromuscular blocking agents, in the intensive care unit setting, curarization is reserved only to some patients. Some of the indications are mechanical ventilation in patients with acute respiratory distress syndrome, septic patients with pulmonary involvement, and prevention of persistent shivering during therapeutic hypothermia. Once decided to use curarization, it is mandatory to assure adequate sedation and analgesia to the patient and an optimal monitoring of the neuromuscular blockade. Curarization has to be discontinued as soon as possible, according to the clinical needs, trying to avoid short- and long-term complications.
References
Appiah-Ankam J, Hunter JM. Pharmacology of neuromuscular blocking drugs. Ceaccp. 2004;4:2–7.
Greenberg SB, Vender J. The use of neuromuscular blocking agents in the ICU: where are we now? Crit Care Med. 2013;41:1332–44.
Burry L, Rose L, McCullagh IJ, Fergusson DA, Ferguson ND, Mehta S. Daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation. Cochrane Database Syst Rev. 2014;9(7):CD009176. https://doi.org/10.1002/14651858.CD009176.pub2.
Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30(1):119–41.
Piriyapatsom A, Bittner EA, Hines J, Schmidt UH. Sedation and paralysis. Respir Care. 2013;58:1024–37.
Doorduin J, Nollet JL, Roesthuis LH, van Hees HWH, Brochard LJ, Sinderby CA, van der Hoeven JG, Heunks LMA. Partial neuromuscular blockade during partial ventilatory support in sedated patients with high tidal volumes. Am J Respir Crit Care Med. 2016;195(8):1033–42.
Alhazzani W, Alshahrani M, Jaeschke R, Forel JM, Papazian L, Sevransky J, Meade MO. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care. 2013;17:R43.
Steingrub JS, Lagu T, Rothberg MB, Nathanson BH, Raghunathan K, Lindenauer PK. Treatment with neuromuscular blocking agents and the risk of in-hospital mortality among mechanically ventilated patients with severe sepsis. Crit Care Med. 2014;42:90–6.
Murray MJ, DeBlock H, Erstad B, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med. 2016;44:2079–103.
Annane D. What is the evidence for harm of neuromuscular blockade and corticosteroid use in the intensive care unit? Semin Respir Crit Care Med. 2016;37:51–6.
Kopman AF, Eikermann M. Antagonism of non-depolarising neuromuscular block: current practice. Anaesthesia. 2009;64:22–30.
Keating GM. Sugammadex: a review of neuromuscular blockade reversal. Drugs. 2016;76:1041–52.
Munshi L, Gershengorn HB, Fan E, Wunsch H, Ferguson ND, Stukel TA, Rubenfeld GD. Adjuvants to mechanical ventilation for acute respiratory failure. Adoption, De-adoption, and factors associated with selection. Ann Am Thorac Soc. 2017;14:94–102.
Buscher H, Vaidiyanathan S, Al-Soufi S, Nguyen DN, Breeding J, Rycus P, Nair P. Sedation practice in veno-venous extracorporeal membrane oxygenation: an international survey. ASAIO J. 2013;59:636–41.
DeGrado JR, Hohlfelder B, Ritchie BM, Anger KE, Reardon DP, Weinhouse GL. Evaluation of sedatives, analgesics, and neuromuscular blocking agents in adults receiving extracorporeal membrane oxygenation. J Crit Care. 2017;37:1–6.
Salciccioli JD, Cocchi MN, Rittenberger JC, et al. Continuous neuromuscular blockade is associated with decreased mortality in post-cardiac arrest patients. Resuscitation. 2013;84:1728–33.
Fortier L-P, McKeen D, Turner K, de Médicis É, Warriner B, Jones PM, Chaput A, Pouliot J-F, Galarneau A. The RECITE study: a Canadian prospective, multicenter study of the incidence and severity of residual neuromuscular blockade. Anesth Analg. 2015;121:366–72.
Sanfilippo F, Santonocito C, Veenith T, Astuto M, Maybauer MO. The role of neuromuscular blockade in patients with traumatic brain injury: a systematic review. Neurocrit Care. 2015;22:325–34.
McGrath CD, Hunter JM. Monitoring of neuromuscular block. Contin Educ Anaesth Crit Care Pain. 2006;6:7–12.
Bouju P, Tadié J-M, Barbarot N, Letheulle J, Uhel F, Fillatre P, Grillet G, Goepp A, Le Tulzo Y, Gacouin A. Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: a prospective descriptive study. Ann Intensive Care. 2017;7:10.
Rudis MI, Sikora CA, Angus E, Peterson E, Popovich J, Hyzy R, Zarowitz BJ. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med. 1997;25:575–83.
Ontario HQ. Bispectral index monitor: an evidence-based analysis. Ont Health Technol Assess Ser. 2004;4:1–70.
Bigham C, Bigham S, Jones C. Does the bispectral index monitor have a role in intensive care? J Intensive Care Soc. 2012;13:314–9.
Tasaka CL, Duby JJ, Pandya K, Wilson MD, Hardin KA. Inadequate sedation during therapeutic paralysis: use of bispectral index in critically ill patients. Drugs Real World Outcomes. 2016;3:201–8.
Christ B, Guerci P, Baumann C, Meistelman C, Schmartz D. Influence of neuromuscular block and reversal on bispectral index and NeuroSense values. Eur J Anaesthesiol. 2014;31:437–9.
Murray MJ, DeBlock HF, Erstad BL, Gray AW, Jacobi J, Jordan CJ, McGee WT, McManus C, Meade MO, Nix SA. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient: 2016 update—executive summary. Am J Heal Pharm. 2017;74:76–8.
Papazian L, Forel J-M, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal J-M, Perez D, Seghboyan J-M. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363:1107–16.
Boddi M, Barbani F, Abbate R, Bonizzoli M, Batacchi S, Lucente E, Chiostri M, Gensini GF, Peris A. Reduction in deep vein thrombosis incidence in intensive care after a clinician education program. J Thromb Haemost. 2010;8:121–8.
Raps EC, Bird SJ, Hansen-Flaschen J. Prolonged muscle weakness after neuromuscular blockade in the intensive care unit. Crit Care Clin. 1994;10:799–813.
De Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Brochard L. Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med. 2004;30:1117–21.
Fletcher SN, Kennedy DD, Ghosh IR, Misra VP, Kiff K, Coakley JH, Hinds CJ. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med. 2003;31:1012–6.
De Jonghe B, Bastuji-Garin S, Durand M-C, Malissin I, Rodrigues P, Cerf C, Outin H, Sharshar T. Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med. 2007;35(9):2007–15.
Latronico N, Bertolini G, Guarneri B, Botteri M, Peli E, Andreoletti S, Bera P, Luciani D, Nardella A, Vittorielli E. Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: the Italian multi-centre CRIMYNE study. Crit Care. 2007;11:R11.
Price DR, Mikkelsen ME, Umscheid CA, Armstrong EJ. Neuromuscular blocking agents and neuromuscular dysfunction acquired in critical illness: a systematic review and meta-analysis. Crit Care Med. 2016;44:2070–8.
Tripathi SS, Hunter JM. Neuromuscular blocking drugs in the critically ill. Contin Educ Anaesth Crit Care Pain. 2006;6:119–23.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Bignami, E., Saglietti, F. (2018). Neuromuscular Blocking Agents. In: De Gaudio, A., Romagnoli, S. (eds) Critical Care Sedation. Springer, Cham. https://doi.org/10.1007/978-3-319-59312-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-59312-8_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59311-1
Online ISBN: 978-3-319-59312-8
eBook Packages: MedicineMedicine (R0)